Clinical Trial

RIG 101 Trial in Healthy Adults and Adults With Asthma

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Nested Phase 1-2 Trial of RIG-101 in Healthy and Asthmatic Participants Assessing Safety, Tolerability and Viral Challenge Efficacy
Trial Details
NCT Number NCT07488897
Lead Sponsor RIGImmune Inc.
Collaborators: Virtus Respiratory Research, Medicines Evaluation Unit Ltd
Conditions Healthy Adult Participants, Asthma Exacerbation, Safety and Efficacy
Enrollment 82 participants
Start Date 2026-02-09
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-23